Aug 30, 2018
The Lancet has published key results from HPTN 074, a randomized, controlled trial conducted among people who inject drugs in Ukraine, Indonesia and Vietnam. Results showed that at 52 weeks from enrollment, participants in the intervention arm nearly doubled their antiretroviral therapy usage, viral suppression and medication-assisted treatment usage compared to the standard of care arm. Mortality was also reduced by more than half with the intervention.
Read the Full Press Release